AR196979A1 - Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo - Google Patents

Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo

Info

Publication number
AR196979A1
AR196979A1 AR23852071A AR23852071A AR196979A1 AR 196979 A1 AR196979 A1 AR 196979A1 AR 23852071 A AR23852071 A AR 23852071A AR 23852071 A AR23852071 A AR 23852071A AR 196979 A1 AR196979 A1 AR 196979A1
Authority
AR
Argentina
Prior art keywords
marek
viable
viruses
disease
suspension
Prior art date
Application number
AR23852071A
Other languages
English (en)
Spanish (es)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of AR196979A1 publication Critical patent/AR196979A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255Marek's disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR23852071A 1970-11-25 1971-10-18 Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo AR196979A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9292070A 1970-11-25 1970-11-25
US17061671A 1971-08-10 1971-08-10

Publications (1)

Publication Number Publication Date
AR196979A1 true AR196979A1 (es) 1974-03-08

Family

ID=26786189

Family Applications (1)

Application Number Title Priority Date Filing Date
AR23852071A AR196979A1 (es) 1970-11-25 1971-10-18 Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo

Country Status (17)

Country Link
JP (1) JPS5750477B1 (cs)
AR (1) AR196979A1 (cs)
AU (1) AU473436B2 (cs)
BE (1) BE775747A (cs)
BR (1) BR7107679D0 (cs)
CA (1) CA935091A (cs)
CH (1) CH581193A5 (cs)
DE (1) DE2158293B2 (cs)
DK (1) DK130796B (cs)
FI (1) FI49522C (cs)
FR (1) FR2115379B1 (cs)
GB (1) GB1374123A (cs)
IE (1) IE35695B1 (cs)
IL (1) IL37849A (cs)
IT (1) IT1035519B (cs)
NL (1) NL7115348A (cs)
PH (1) PH11064A (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
GB2086408B (en) * 1980-10-16 1985-10-09 Oreal New nitro-derivatives of the benzene series the process for their preparation and their use in the dyeing of keratin fibres
ZA874625B (en) * 1986-06-30 1988-10-26 Smith Kline Rit Stabilizers for live vaccines,process for their preparation and vaccines containing them
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病2価生ワクチンとその製造方法

Also Published As

Publication number Publication date
FI49522B (cs) 1975-04-01
AU473436B2 (en) 1976-06-24
CH581193A5 (cs) 1976-10-29
IE35695B1 (en) 1976-04-28
NL7115348A (cs) 1972-05-29
FR2115379B1 (cs) 1977-01-07
JPS5750477B1 (cs) 1982-10-27
DE2158293B2 (de) 1979-01-25
DK130796B (da) 1975-04-14
GB1374123A (en) 1974-11-13
CA935091A (en) 1973-10-09
IT1035519B (it) 1979-10-20
AU3442071A (en) 1973-04-19
IL37849A0 (en) 1971-12-29
BR7107679D0 (pt) 1973-07-03
DK130796C (cs) 1975-10-06
FI49522C (fi) 1975-07-10
IL37849A (en) 1975-04-25
BE775747A (fr) 1972-05-24
PH11064A (en) 1977-10-25
DE2158293A1 (de) 1972-06-08
IE35695L (en) 1972-05-25
FR2115379A1 (cs) 1972-07-07

Similar Documents

Publication Publication Date Title
ES496358A0 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
IT8224948A0 (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo.
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
AR194587A1 (es) Procedimiento para la preparacion de 2,2'metilendifenoles sustituidos
AR205004A1 (es) Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
AT304473B (de) Verfahren zur Herstellung von neuen substituierten 1-Amino-2-hydroxy-3-[2'-cyclopentyl- bzw. (δ<2>-cyclopentenyl)-phenoxy]-propanen, deren optisch aktiven Isomeren und Salzen
BE799379R (fr) Amino-alcools et leur preparation.
AR198639A1 (es) Procedimiento para preparar 2,3- cis -1, 2, 3, 4-tetrahidro-5-<2-hidroxi-3-amino substituido propoxi>-2,3-naftalenodioles
AR196979A1 (es) Procedimiento para la preparacion de una suspension de virus de la enfermedad de marek, exentos de celulas, viables y estables con un elevado titulo
DK133311B (da) Fremgangsmade til fremstilling af en vaccine til bekempelse af marek's syge indeholdende levende ikke-svekket, celleassocieret virus
BE772634A (fr) Nouveaux dihydrobenzofuranyl-n-methylcarbamates n-sulfenyles, leur procede de preparation et leur utilisation comme insecticides etacaricides
BE789852A (fr) Composes polyanioniques, leur procede de preparation et leur utilisation
AR202999A1 (es) Procedimiento para la preparacion de 1,4-ioxido de 2-(2oxazolin-2-il)-3-metilquinoxalina
IT7829209A0 (it) Prodotto di condensazione ottenuto da fenotiazina e da p-nitrosofenolo, procedimento per la preparazione del prodotto di condensazione, procedimento per lapreparazione di coloranti allo zolfo con impiego del prodotto di condensazione e i coloranti allo zolfo preparati.
AR201878A1 (es) Procedimiento para preparar una vacuna inmunizante y no patogena
BE765369A (fr) '6-cyano-thio-glucosides, leurs intermediaires et leur preparation
AR204433A1 (es) Colorantes derivados del 4,6-dinitro-4'-n,n-dietilamino-1,1'-azobenceno y procedimiento para obtenerlos
BE771770A (fr) Composes de l'anthraquinone, leur preparation et leur application
BE768985A (fr) Benzoxetane-2-spiro-2'-(1',3'-diazacycloalkanes) et leur preparation
BE769130A (fr) Benzothietane-2-spiro-2'-(1',3'-diazocycloalkanes) et leur preparation
BE766870A (fr) Benzimidazoles, leur preparation et leur utilisation comme agents acaricides
MX5864E (es) Procedimiento mejorado para la preparacion de derivados del 2-bromo-ergoleno y del 2-bromo-ergolino
AR201121A1 (es) Procedimiento para la preparacion de 2,2'-anhidro-1beta-d-arabinofuranosil-5-fluorocitosina
SE414306B (sv) Forfarande for framstellning av 1,4-bensodiazepiner
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same